Added to YB: 2025-10-30
Pitch date: 2025-10-28
CRMD [bullish]
CorMedix Inc.
+2.91%
current return
Author Info
Back of the Napkin Bios shares highly digestible high conviction names in bio land. Sign up for the newsletter.
Company Info
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Market Cap
$885.6M
Pitch Price
$11.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.02
P/E
4.99
EV/Sales
4.57
Sector
Pharmaceuticals
Category
growth
CorMedix Inc.: De-Risked, Undervalued, and Firing on All Cylinders
CRMD: Biopharm co w/ DefenCath (antimicrobial catheter lock) showing explosive growth - Q3 revs $85M (+113% QoQ), beating consensus 50%+. Mgmt raised 2025 guidance to $375M+ vs $871M mkt cap. Consistent guidance beats across 4 qtrs. Phase III showed 71% CRBSI risk reduction. Melinta acquisition added diversified anti-infective portfolio for commercial expansion.
Read full article (1 min)